Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > COVID-19

COVID-19

Covid-19 Related Enlisted/Registered Medical Devices for Import Under MDR, 2017

Ijaz Mustafa COVID-19 August 31, 2021January 18, 2022
covid_devices_list-1Download

Procedure to Administer COVID-19 Vaccine By Private Healthcare Facilities

Ijaz Mustafa COVID-19 April 2, 2021January 18, 2022
Download

Application for No Objection Certificate Under S. R. O. 135(I)2021 Dated 2nd February, 2021.

Ijaz Mustafa COVID-19 February 18, 2021January 18, 2022
Download

FAQ’s regarding import of COVID-19 Vaccine in Pakistan

Ijaz Mustafa COVID-19 February 11, 2021January 18, 2022
FREQUENTLY-ASKED-QUESTIONSDownload

Application for No Objection Certificate Under S. R. O. 135(I)2021 Dated 2nd February, 2021.

Ijaz Mustafa COVID-19 February 2, 2021January 18, 2022

APPLICATION FOR NO OBJECTION CERTIFICATE UNDER S. R. O.
135(I)2021 DATED 2ND FEBRUARY, 2021

Application-for-NOC-1-1Download

Priority Approval/Registration of Favipiravir Drugs During the COVID-19 Pandemic

Ijaz Mustafa COVID-19 July 14, 2020January 18, 2022
Favipiravir_priority-approval_registration-of-drugs-during-the-covid-19-pandemicDownload

Using Medicines Safely During the COVID-19(In Urdu)

Ijaz Mustafa COVID-19 July 7, 2020January 18, 2022
Safe-medicines-COVID-DRAP-UrduDownload

Using Medicines Safely During the COVID-19(In English)

Ijaz Mustafa COVID-19 July 7, 2020January 18, 2022
Safe-medicines-COVID-DRAP-EnglishDownload

Use of REMDESIVIR in the current COVID-19 Pandemic

Ijaz Mustafa COVID-19 June 19, 2020January 18, 2022
Use-of-remdesivir-in-the-current-covid-19-pandemic.-F-1Download

Priority Approval/Registration of Drugs Remdesivir and Tocilizumab During the COVID-19 pandemic

Ijaz Mustafa COVID-19 June 15, 2020January 18, 2022
Priority-Approval_Registration-of-Drugs-Remdesivir-and-Tocilizumab-During-the-COVID-19-pandemicDownload
  • ← Previous
  • New & Updates
  • COVID-19 Drugs Availability
  • Government of Pakistan COVID-19 Portal
  • National Command Operation Center (NCOC)
  • Ministry of NHSR&C
  • WHO – Coronavirus disease

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem